Red Apple Group, Wilson Sonsini Goodrich & Rosati, Mitsubishi Tanabe Pharma Corporation and Alexandria Real Estate Equities have all invested in the antibiotics developer.

Vegetarian protein substitute developer Nutriati has raised $8m in a round led by Tate & Lyle Ventures, which has also taken a board seat at the company.

Lyndra, which is developing a slow-release oral medication platform, has closed a series A round featuring Partners Healthcare as it prepares to begin human trials.

Comcast has reportedly led a funding round for the adaptive wifi technology provider that stands at $32.6m according to a securities filing.

Frequency Therapeutics is working on a progenitor cell-related treatment for hearing loss based on research conducted at MIT and Harvard Medical School.

Zaluvida has boosted the series A round raised by Targedys, which is working on products to regulate the appetite, to a total of $11.1m over the past year.

Frequency Therapeutics, which is working on a progenitor cell-related treatment for hearing loss, has closed a round featuring Alexandria Real Estate Equities.

Pharmaceutical firm Novo and Frazier Healthcare Partners co-led a round that will be used to advance the company's liver disease treatment through phase 2b trials.